PestleMedicine Explained

Insulin glulisine

Apidra is a fast-acting antidiabetic medicine (insulin) used to reduce high blood sugar in people with diabetes mellitus. It can be given to adults, adolescents and children aged 6 years and older.

Active ingredient: Insulin glulisine

Official leaflet

Key facts

  1. Apidra starts to work within 10 to 20 minutes and lasts about 4 hours.
  2. It is injected under the skin shortly (0 to 15 minutes) before or soon after meals, and injection sites must be rotated.
  3. Low blood sugar (hypoglycaemia) is a very common side effect and can be serious, so always carry some sugar (at least 20 grams) and information showing you have diabetes.
  4. Do not stop using Apidra without speaking to a doctor, as this could lead to severe high blood sugar and ketoacidosis.
  5. Always check the insulin label before each injection to avoid mix-ups with other insulins.

Who should not take insulin glulisine

The leaflet says not to take it if any of these apply to you.

  • If you are allergic to insulin glulisine or any of the other ingredients of this medicine
  • If your blood sugar is too low (hypoglycaemia)

Check with a doctor or pharmacist first

Tell them before you take it if any of these apply to you.

  • The pre-filled pen is only suitable for injecting just under the skin; speak to your doctor if you need to inject by another method
  • Follow closely the instructions on dose, monitoring (blood tests), diet and physical activity discussed with your doctor
  • If you have liver or kidney problems, you may need a lower dose
  • There is insufficient clinical information on use in children younger than 6 years
  • Rotate the injection site to prevent skin changes such as lumps; the insulin may not work well if injected into a lumpy area, so contact your doctor if you are doing this before changing area
  • Talk to your doctor before travelling (insulin supplies, storage, meal and injection timing, time zones, emergencies)
Show 6 moreShow fewer
  • If you are ill or have a major injury, blood sugar may rise; if you are not eating enough, blood sugar may become too low; contact a doctor early
  • If you have type 1 diabetes, do not stop your insulin and continue to get enough carbohydrates
  • Heart failure has been seen in some patients with long-standing type 2 diabetes and heart disease or previous stroke treated with pioglitazone and insulin; tell your doctor if you have unusual shortness of breath, rapid weight increase or localised swelling (oedema)
  • Alcohol may make your blood sugar rise or fall
  • Your ability to concentrate or react may be reduced if your blood sugar is too low or too high, so take care when driving or using machines
  • Apidra contains metacresol, which may cause allergic reactions

How to take insulin glulisine

  • Use it exactly as your doctor has told you; your doctor decides how much you need based on your life-style, blood sugar tests and previous insulin use.
  • Inject under the skin of the abdominal wall, thigh or upper arm, shortly (0 to 15 minutes) before or soon after meals, and rotate injection sites each time.
  • Before use, attach a new needle and do a safety test; only use the solution if it is clear, colourless and has no visible particles, and do not shake or mix it.
  • Each pen must be used by one patient only; follow the SoloStar Instructions for Use.
  • If you miss a dose, check your blood sugar frequently and do not take a double dose to make up for it.

Side effects

Get medical help straight away

The leaflet says to get help urgently, or to stop the medicine and speak to a doctor, if you notice any of these. In an emergency call 999.

  • Hypoglycaemia (low blood sugar), which can be very serious and may cause unconsciousness, brain damage and be life-threatening (very common, may affect more than 1 in 10 people)
  • Systemic allergic reactions (uncommon, may affect up to 1 in 100 people): contact your doctor immediately
  • Generalised allergy to insulin, with symptoms such as rash and itching all over the body, severe swelling of skin or mucous membranes (angioedema), shortness of breath, a fall in blood pressure with rapid heart beat and sweating, including anaphylactic reaction which may be life-threatening (listed with systemic allergic reactions, uncommon)
  • Hyperglycaemia (high blood sugar), which can be serious if blood glucose becomes very high; severe hyperglycaemia or ketoacidosis must be treated by a doctor (frequency cannot be estimated)

How common each side effect is

Grouped the way the leaflet groups them. Most people get none, or only a few. Each figure is the most that are affected, so "up to 1 in 10" can mean far fewer.

Very common

More than 1 in 10 people

  • Hypoglycaemia (low blood sugar)

Common

Up to 1 in 10 people

  • Skin and allergic reactions at the injection site (reddening, unusually intense pain on injection, itching, hives, swelling or inflammation)

Uncommon

Up to 1 in 100 people

  • Systemic allergic reactions (generalised allergy to insulin, including anaphylactic reaction)

Rare

Up to 1 in 1,000 people

  • Lipoatrophy (shrinking of fatty tissue at the injection site)
  • Lipohypertrophy (thickening of fatty tissue at the injection site)

Not known

The leaflet says how often is not known

  • Cutaneous amyloidosis (lumps under the skin caused by build-up of amyloid)
  • Hyperglycaemia (high blood sugar)
  • Eye reactions (temporary disturbance of vision after a marked change in blood sugar control; temporary loss of vision with severe hypoglycaemic attacks if you have proliferative retinopathy)

If you get a side effect, you can report it to the regulator through the Yellow Card scheme.

Pregnancy and breastfeeding

Ask your doctor or pharmacist for advice before use if you are pregnant, may be pregnant, are planning a baby or are breast-feeding. Your insulin dose may need to change during pregnancy and after giving birth, and careful diabetes control is important for your baby's health; there are no or limited data on use in pregnant women.

Taking it with other medicines

The leaflet says to tell your doctor or pharmacist if you take any of these. This list is not checked against the medicines you take.

  • Tell your doctor or pharmacist about any other medicines you are taking, have recently taken or might take
  • Medicines that may lower blood sugar: all other medicines to treat diabetes, ACE inhibitors, disopyramide, fluoxetine, fibrates, MAO inhibitors, pentoxifylline, propoxyphene, salicylates (such as aspirin), sulphonamide antibiotics
  • Medicines that may raise blood sugar: corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens (such as in the contraceptive pill), phenothiazine derivatives, somatropin, sympathomimetic medicines (such as epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, protease inhibitors, atypical antipsychotic medicines (such as olanzapine and clozapine)
  • Medicines that may raise or lower blood sugar: beta-blockers, clonidine, lithium salts
  • Pentamidine, which may cause hypoglycaemia sometimes followed by hyperglycaemia
  • Beta-blockers, clonidine, guanethidine and reserpine may weaken or hide the first warning symptoms of hypoglycaemia

Where this comes from

Everything on this page is taken from one official document: the patient information leaflet that the UK medicines regulator (MHRA) approved for this product. Pestle reorganises it and puts it in plainer words. It adds nothing from anywhere else and does not rate medicines.

Product
Apidra Solostar 100 Units/ml Solution For Injection In A Pre-Filled Pen
Product licence
PLPI151842151
Leaflet dated
Checked against the leaflet
Automated check
7 of 8 side effects matched to the wording of the leaflet. 1 could not be matched and need a manual check

Other makers of insulin glulisine publish their own leaflets, which can differ slightly. Always read the leaflet that came with your medicine.

Read the official leaflet Original on the MHRA site How we make these pages

The same facts for software and AI agents: JSON · Markdown.